3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, GY; Chang, WC; Kuo, SC; Teng, CM; Wu, CH | 1 |
| Bascands, JL; Bouloumié, A; Decaunes, P; Gres, S; Langin, D; Rancoule, C; Saulnier-Blache, JS; Valet, P; Viaud, M; Viguerie, N | 1 |
1 trial(s) available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and transforming growth factor beta
| Article | Year |
|---|---|
Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.
Topics: Actins; Adipose Tissue; Animals; Collagen; Enzyme Activators; Female; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Isoxazoles; Lysophospholipids; Male; Mice; Mice, Obese; Propionates; Receptors, Lysophosphatidic Acid; Tissue Culture Techniques; Transforming Growth Factor beta | 2014 |
1 other study(ies) available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and transforming growth factor beta
| Article | Year |
|---|---|
The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study.
Topics: Administration, Topical; Animals; Aorta, Thoracic; Carotid Artery, Common; Catheterization; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glyceraldehyde-3-Phosphate Dehydrogenases; Guanylate Cyclase; Imidazoles; Indazoles; Muscle, Smooth, Vascular; Poloxamer; Protein-Tyrosine Kinases; Rats; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled; Receptors, Peptide; RNA, Messenger; Transforming Growth Factor beta; Tunica Intima | 2004 |